| Source HCPCS Code |
|
Target NDC Code |
J8520
CAPECITABINE, ORAL, 150 MG
|
⇄
|
00004-1100-20
XELODA 150 MG
|
| Detail Information |
| Relationship Start Date |
1/28/2005 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
60 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
J8520
CAPECITABINE, ORAL, 150 MG
|
⇄
|
00004-1100-51
XELODA 150 MG
|
| Detail Information |
| Relationship Start Date |
1/28/2005 |
| Relationship End Date |
4/1/2007 |
| Number Of Items In Ndc Package |
120 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
J8520
|
⇄
|
00093-7473-06
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J8520
|
⇄
|
00378-2511-91
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J8520
|
⇄
|
54569-5712-00
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J8520
|
⇄
|
54569-5713-00
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J8520
CAPECITABINE, ORAL, 150 MG
|
⇄
|
54868-4143-00
XELODA 150 MG
|
| Detail Information |
| Relationship Start Date |
2/10/2005 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
60 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
J8520
CAPECITABINE, ORAL, 150 MG
|
⇄
|
54868-4143-01
XELODA 150 MG
|
| Detail Information |
| Relationship Start Date |
8/8/2007 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
120 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
J8520
CAPECITABINE, ORAL, 150 MG
|
⇄
|
54868-4143-02
XELODA 150 MG
|
| Detail Information |
| Relationship Start Date |
10/19/2005 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
J8520
CAPECITABINE, ORAL, 150 MG
|
⇄
|
54868-4143-03
XELODA 150 MG
|
| Detail Information |
| Relationship Start Date |
5/19/2006 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
28 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
J8520
Capecitabine, oral, 150 mg
|
⇄
|
16729-0072-12
CAPECITABINE
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J8520
Capecitabine, oral, 150 mg
|
⇄
|
65162-0843-06
CAPECITABINE
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J8520
Capecitabine, oral, 150 mg
|
⇄
|
72485-0204-60
CAPECITABINE
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J8520
Capecitabine, oral, 150 mg
|
⇄
|
68001-0487-06
CAPECITABINE
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J8520
Capecitabine, oral, 150 mg
|
⇄
|
69097-0949-03
CAPECITABINE
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J8520
Capecitabine, oral, 150 mg
|
⇄
|
00004-1100-20
Xeloda
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J8520
Capecitabine, oral, 150 mg
|
⇄
|
00054-0271-21
CAPECITABINE
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J8520
Capecitabine, oral, 150 mg
|
⇄
|
70756-0815-60
CAPECITABINE
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J8520
Capecitabine, oral, 150 mg
|
⇄
|
00378-2511-91
CAPECITABINE
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J8520
Capecitabine, oral, 150 mg
|
⇄
|
16714-0467-01
CAPECITABINE
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J8520
Capecitabine, oral, 150 mg
|
⇄
|
00093-7473-06
CAPECITABINE
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|